{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:12:34Z","timestamp":1791947554906,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000019","name":"National Hemophilia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.jvca.2021.01.038","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T09:51:45Z","timestamp":1611741105000},"page":"724-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor"],"prefix":"10.1053","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0122-9320","authenticated-orcid":false,"given":"Glaivy","family":"Batsuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-7200","authenticated-orcid":false,"given":"Karen L.","family":"Zimowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Robert F.","family":"Sidonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2021.01.038_bib0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.01.038_bib0002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.hoc.2019.01.010","article-title":"von Willebrand disease in pediatrics: Evaluation and management","volume":"33","author":"O'Brien","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.jvca.2021.01.038_bib0003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2021.01.038_bib0004","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/jth.14208","article-title":"Acquired von Willebrand syndrome in congenital heart disease surgery: Results from an observational case-series","volume":"16","author":"Icheva","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.01.038_bib0005","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2012-10-435719","article-title":"Treatment of acquired von Willebrand syndrome in childhood","volume":"122","author":"Callaghan","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2021.01.038_bib0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: Data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.01.038_bib0007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2516.2006.01217.x","article-title":"Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections","volume":"12","author":"Bidlingmaier","year":"2006","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2021.01.038_bib0008","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1345\/aph.1A338","article-title":"Continuous infusion of coagulation factor products","volume":"36","author":"Stachnik","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2021.01.038_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0037-1614448","article-title":"Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease","volume":"81","author":"Lubetsky","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2021.01.038_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00001721-199701000-00002","article-title":"Continuous infusion therapy with very high purity von Willebrand factor concentrate in patients with severe von Willebrand disease","volume":"8","author":"Smith","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2021.01.038_bib0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/088800199276859","article-title":"Continuous infusion of von Willebrand factor and factor VIII after elective heart surgery in a 12-year-old girl with von Willebrand disease type 3","volume":"16","author":"Kuhne","year":"1999","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1053\/j.jvca.2021.01.038_bib0012","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: A prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2021.01.038_bib0013","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2021.01.038_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13436","article-title":"Advantage of recombinant von Willebrand factor for peri-operative management in paediatric acquired von Willebrand syndrome","volume":"24","author":"Weyand","year":"2018","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2021.01.038_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","article-title":"Elevated factor VIII levels and risk of venous thrombosis","volume":"157","author":"Jenkins","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2021.01.038_bib0016","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1111\/j.1365-2516.2012.02758.x","article-title":"Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: A systematic review of prospective studies","volume":"18","author":"Coppola","year":"2012","journal-title":"Haemophilia"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077021000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:55:33Z","timestamp":1760946933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077021000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1053077021000756"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2021.01.038","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2021.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}